Hyper Polarized Xenon-129 MRI vs Xenon-133 Scintigraphy
Part of paid clinical trials in Charlottesville, Virginia.
- Sponsor
- University of Virginia
- Study ID
- NCT03331302
- Phase
- PHASE1/PHASE2
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Hyperpolarized Xenon-129 MRI (Experimental) — DRUGMRI ventilation scan of the lung with inhaled contrast agent (hyperpolarized Xenon-129)
- Radioactive Xenon-133 scintigraphy (Active Comparator) — DRUGRadioactive ventilation scintigraphy of the lung with inhaled radioactive contrast agent (Xenon-133)
Study Details
Hyper polarized Xenon-129 MRI will be directly compared to a radioactive Xe-133 scintigraphy to detect defects in lung ventilation from airflow limitation. This study is conducted as a pilot study with intention to conduct a larger clinical trial.
Key Dates
- Start date
- Sep 1, 2018
- Status verified
- Nov 2020
- Primary completion
- Jun 30, 2020
- Completion
- Dec 31, 2020
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- DIAGNOSTIC
Arms
- Active Comparator: COPD patients - Xe-133COPD patients who will be assessed with Xenon-133 scintigraphy (Standard diagnostic study)
- Experimental: COPD patients - Hyperpolarized Xe-129COPD patients crossed over from the Active Comparator Arm who will be assessed with hyper polarized Xenon-129 MRI (Experimental diagnostic study)
Primary Outcome Measure
Ventilation imaging resolution comparison between MRI and scintigraphy [ Time Frame: 12 months ]
Central Contacts
- Sarah Struchen, RN4342436074
- Roselove Nunoo-Asare, RT4342437363
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Virginia Health System | Charlottesville | Virginia | 22908 | Mike Shim, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Charlottesville, VA
By condition
By specialty
By research site
Related Studies
- A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)PHASE3 · Recruiting · Hoffmann-La Roche · Birmingham, Alabama
- Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPDRecruiting · Nuvaira, Inc. · Birmingham, Alabama
- Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic PhenotypePHASE3 · Recruiting · Sanofi · Chandler, Arizona
- Emphysema Research Registry and Biosample RepositoryRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania